In the present study, GPER was downregulated in HCC tissue compared with that in matched non-tumor counterparts, and GPER-specific agonist G1-triggered GPER/EGFR/ERK signaling played a crucial role in decreasing the tumor viability of HCC, both in vitro and in vivo. This evidence concerns the gene EGFR and hepatocellular carcinoma.